Introduction
Candidemia and other forms of deeply invasive candidiasis represent an increasing cause of morbidity and mortality in hospitalized patients. The accurate diagnosis of these infections can be critical to early and effective therapy. Moreover, the ability to correctly identify isolates of Candida spp. recovered in culture can have direct bearing on therapeutic choice and effectiveness. In particular, while Candida albicans remains the most common species of yeast recovered from clinical specimens, some non-C. albicans Candida spp., including C. glabrata , C. krusei , C. tropicalis , C. parapsilosis , C. lusitaniae and C. guillermondii are being seen and may be resistant to front-line antifungal agents [1, 2] .
The rapid and accurate identifi cation of such organisms can be challenging. Morphologic differentiation requires sequences therefore results in variably sized amplicons. Size-based analysis of these amplicons provides a ' molecular fi ngerprint ' that can be used for strain typing of bacteria, and potentially for genus or species-level identifi cation of fungal isolates [9 -11] . PCR/ESI-MS can be coupled to computer algorithms to determine amplicon base-pair composition as surrogate means of sequence identifi cation [12, 13] . This method has been used for broad range identifi cation of bacterial and viral pathogens [12,14 -16] . However, little is known about its applicability to the detection and identifi cation of clinically relevant fungi.
The present study is the fi rst to our knowledge to compare rep-PCR to PCR/ESI-MS and sequencing for the identifi cation of fungal isolates. It provides proof-of-principle that further adaptation of these methods may allow for the rapid identifi cation of such pathogens, potentially improving diagnostic speed and accuracy in these sometimes challenging cases.
Materials and methods

Fungal isolates and experimental design
Fungal isolates used in the study included 76 wellcharacterized reference strains of clinically relevant Candida species (a total of 14 species including C. albicans , C. colliculosa , C. dubliniensis , C. famata , C. guillermondii , C. kefyr , C. krusei , C. lusitaniae , C. norvagensis , C. parapsilosis , C. rugosa , C. sphaerica , C. tropicalis and C. glabrata ) and 61 de-identifi ed clinical Candida isolates. The latter were recovered from clinical samples obtained from 61 unique immunocompromised pediatric oncology and bone marrow transplant patients. Institutional review board (IRB) approval was given prior to the start of this study. Known fungal strains were used to build a library of spectral signatures (PCR/ESI-MS) and to generate rep-PCR patterns, supplementing the pre-existing DiversiLab rep-PCR database (BioM é rieux, Inc., Marcy l ' Etoile, France). Both experimental methods were then challenged with the clinical isolates and results compared to sequencebased identifi cation, using the internal transcribed spacer (ITS) region as a target.
DNA extraction
Yeast strains were grown on 5% blood agar plates at 37 ° C for 24 -48 h. DNA was extracted from two 10 μ l loops of cellular material using the Mo Bio Ultra Clean Microbial DNA Isolation Kit (MO BIO Laboratories, Inc., Carlsbad, CA, USA) according to manufacturer ' s instructions. DNA was eluted in a fi nal volume of 50 μ l of Solution MD5 and stored at Ϫ 20 ° C prior to use.
Repetitive sequence PCR
The DiversiLab Micorbial Genotyping System (Bio-M é rieux) was used to generate rep-PCR DNA fi ngerprints of Candida isolates. Briefl y, the rep-PCR of Candida samples was performed using the DiversiLab Yeast Kit in a 25 μ l reaction mix containing 2 μ l primer mix T, 2.5 μ l GeneAmp 10 ϫ PCR buffer (ABI), 0.5 μ l (5U/ μ ) AmpliTaq DNA Polymerase (ABI), and 50 ng sample DNA. Thermal cycling started at 94 ° C for 2 min, followed by 35 cycles of denaturation at 92 ° C for 30 s, annealing at 50 ° C for 30 s, and extension at 70 ° C for 90 s, fi nishing at 70 ° C for 3 min on a DNA Engine Tetrad (PTC-225, MJ Research) instrument. The PCR product was separated for DNA fi ngerprint on DiversiLab DNA chip using the Agilent 2100 Bioanalyzer. The fi ngerprints from various samples were analyzed using the DiversiLab Software against an enhanced yeast library constructed in the study. The preexisting DiversiLab yeast library was enhanced by adding 34 well-characterized reference strains of clinically relevant Candida species prior to testing unknown samples. The enhanced library differed by the addition of C. guilliermondii , C. kefyr and C. norvegensis . The number of strains of C. famata and C. rugosa also was increased from one of each to four of each in the enhanced library. There were at least 2 -3 strains from each species of Candida in the library.
PCR/electrospray ionization mass spectrometry
A generalized fungal identifi cation kit based upon the Ibis biosensor concept [13, 17, 18] was used for PCR and mass spectrometry-based species identifi cation of Candida isolates which employed a panel of 16 primer pairs (Table 1) . Frozen PCR assay plates were pre-formulated with 30 μ l of master mix per well which contained all components other than enzyme and DNA template. DNA template (5 μ l) and Taq polymerase were added to each reaction (40 μ l fi nal volume). Reactions contained 20 mM Tris-Cl, 75 mM KCl, 1.5 mM MgCl 2 , 400 mM betaine, 20 mM D-sorbitol, 80 ng/reaction poly-A, 200 μ M dNTPs (BioLine, Taunton, MA), 250 nM forward and reverse primers (IDT, Coralville, IA, USA), and 100 copies of an internal calibrant construct consisting of a target DNA sequence derived from a published sequence representing an organism of interest (see Table 1 for GenBank accession numbers), cloned into a commercially-available vector (BlueHeron, pUCminusMCS, BlueHeron, Bothell, WA, USA). Calibrant constructs were designed with several nucleotides deleted from or added to the basic target sequences (to make them different than natural fungal sequences) and served as internal positive controls and semi-quantitative PCR competitors to gauge input template to 30 s at 48 ° C ( ϩ 0.9 ° C per cycle), ramp 26% to 30 s at 72 ° C; 37 cycles of ramp 15% to 15 s at 95 ° C, ramp 18% to 20 s at 56 ° C, ramp 15% to 20 s at 72 ° C; and 2 min at 72 ° C. Mass spectrometry and data analysis were performed as previously described using an Ibis Biosciences T5000 instrument [17, 18] .
To build a base composition signature database for PCR/ESI-MS Candida spp. identifi cation, 76 Candida reference strains were prepared from dry pellets obtained directly from the ATCC (Manassas, VA, USA). After breaking the ampoules or opening tubes, pellets were suspended in 1 ml Hardy Diagnostics R34 TSB ϩ 15% glycerol (Hardy Diagnostics, Santa Maria, CA, USA), from which 700 μ l were stored at Ϫ 80 ° C, and 300 μ l were extracted with an Ambion MagMax TM Total Nucleic Acid Isolation kit (Ambion, Austin, TX, USA). We utilized two 5-min bead beating sessions on a Biospec Mini BeadBeater-16 (Model 607, Biospec, Bartlesville, OK, USA) and nucleic acid isolation on a Thermo Scientifi c KingFisher Flex Magnetic Particle Processor (Thermo Scientifi c, Waltham, MA, USA) with a fi nal elution into 200 μ l 0.1 mM EDTA (AM 9912, Ambion, Austin, TX, USA). Eluates were diluted 1:10 and run in the fungal identifi cation kit described above. For each PCR product produced in the 16 PCR reactions for each isolate analyzed, the base composition (count of A, G, C and T residues) was calculated from the forward and reverse strand masses of the PCR product resulting from mass spectrometry analysis, as previously described [17, 18] . Base compositions derived for each isolate analyzed were used to populate a database utilized in identification of Candida spp. from unknown samples.
DNA sequencing and sequence analysis
The ITS regions of Candida spp. were amplifi ed using previously described primers [19] . Approximately 25 ng of DNA was used to perform PCR of the ITS region using the SYBR Green PCR Master Mix kit (Applied Biosystems,Inc, Foster City, CA, USA) and an ABI 7500 Sequence Detection System Instrument (Applied Biosystems). The amplifi ed products were purifi ed using QIAquick PCR purifi cation kit (QIAGEN, Valencia, CA, USA) and sequenced with primers ITS1, ITS2, ITS3, and ITS4 using Big Dye Terminator (v3.1) chemistry on Applied Biosystem 3730XL DNA Analyzers (Applied Biosystems). Sequences obtained from each sample were aligned and edited using a software suite for sequence analysis-DNAS-TAR Lasergene version 7 (DNASTAR, Inc., Madison, WI, USA). Homology of the sequence was identifi ed in the non-redundant (nr) database of GenBank (NCBI) using the same software suite.
Statistical analysis
Accuracy in identifi cation was measured by calculating proportion of samples correctly identifi ed over all clinical samples for each test, along with 95% confi dence intervals. The 95% confi dence intervals were calculated using the score confi dence interval method [20] .
Results
Reference strains were used to train both systems and both provided concordant and correct results for these isolates, based on ATCC designated genospecies. Most de-identifi ed clinical Candida isolates (58 of 61 (95.1%, confi dence interval, CI, 86.5 -98.3%) were identifi ed by sequencing with a high degree of confi dence ( Ն 99% sequence match).
Rep-PCR resulted in species-level identifi cation of 54 isolates (88.5%, CI 72.8 -94.3%), while PCR/ESI-MS identifi ed 57 isolates (93.4%, CI, 84.3 -97.4%) based on validation criterion of each method. An example of PCR/ESI-MS differentiation of nine Candida species with one of the seven primer pairs from Table 1 that contribute to Candida species identifi cation is shown in Fig. 1 . Note that base composition signatures from seven PCR primers, not just one, contribute to the identifi cation of species, as described previously for microbial species in general [15, 16] . Results from both experimental systems and of sequence-based analysis are shown in Table 2 . Pair-wise comparison of rep-PCR and PCR/ESI-MS results to those of DNA sequencing using the 58 sequence-validated clinical isolates showed that both rep-PCR and PCR/ESI-MS correctly identifi ed 51 of the 58 isolates to the species level (87.9%).
Sequencing showed that six of seven isolates incorrectly identifi ed by the two experimental methods represented species not contained in their reference libraries. Three of these six were isolates of P. carribica, one identifi ed as C. famata by PCR/ESI-MS and the other two as C. guilliermondii by both methods. Three isolates of C. pararugosa (also absent from the reference libraries) were tested. One was identifi ed as C. glabrata and one as C. rugosa by PCR/ESI-MS; none were identifi ed by rep-PCR. After excluding the six isolates not contained in the reference libraries, a total of 52 samples validated by sequencing were used to calculate an accuracy of 98.1% (CI, 89.9 -99.7%) for both methods.
Turnaround time for both methods was approximately 4 -6 h, with limited hands-on time requirements. PCR/ESI-MS has a high sensitivity and may eventually show utility for direct detection applications, as well as for identifi cation (shown here).
Fig. 1 Discrimination of yeast species using base composition derived through PCR/ESI-MS. Mass spectrometry signals for nine different Candida
spp. generated with primer pair 3766 are shown (see Table 1 ). Base compositions of PCR products are derived mathematically from product masses [15, 16] . This single primer pair differentiates all nine of these species by nature of the information provided in the amplifi ed product. Six additional primer pairs in the ESI-MS-based panel (Table 1 ) also contribute to Candida spp. detection and identifi cation through a combination of presence or absence of amplifi cation and base composition of amplifi ed products. Robust speciation of Candida spp. does not rely upon the signature from a single primer pair. For masses that look qualitatively close at the resolution of this image, vertical lines are drawn to highlight the separation from other PCR product strand masses. * Masses for C. albicans base composition of [A36 G39 C31 T42] are 46069.96 Da (forward) and 45793.97 Da (reverse), whereas those for C. tropicalis base composition of [A37 G38 C29 T44] are 46074.11 Da (forward) and 45757.23 Da (reverse). The forward strand masses 46069.96 Da and 46074.11 appear to be quite similar, but they are 3 -6 ϫ greater than the safe mass deviation range achieved with the current instrumentation, the reverse strand masses are quite different, and both strand masses are required to calculate the observed base composition [15, 16] . ¥ C. colliculosa was not part of the blinded panel tested, but was included in a panel of species used to develop database signatures and is included to demonstrate specifi city relative to other Candida spp.
Discussion
Molecular methods, including rep-PCR and PCR/ESI-MS offer promise for the rapid identifi cation of fungal species. In the present study, the data showed accuracy nearly equal to that of the reference standard, with a turnaround time shorter than most currently employed phenotypic methods.
The strength of such phenotypic methods lies in the diagnosis of C. albicans and a few other more commonly isolated yeast species. However, it is clear that their efficacy is reduced when dealing with less common clinical strains [3] . The need for such capability is warranted by studies showing a correlation between species and responsiveness to empiric antimicrobial therapy [1, 2] . This, together with changing epidemiology, suggests the clinical value of a rapid and accurate means of identifi cation to the species-level.
To date, markedly improved identifi cation has been achieved through primarily the use of sequence-based techniques. Primarily focusing on the ITS region, numerous studies have established sequencing as a reference standard for identifi cation of Candida species [3 -5,21] . However, sequencing remains a somewhat cumbersome process, requiring specialized skills for proper performance, and not typically well-suited for easy integration in the clinical laboratory. Both rep-PCR and PCR/ESI-MS offer the possibility of fi lling this role.
Rep-PCR has lower associated costs and more limited complexity, but also has lower sensitivity, requiring nanogram quantities of DNA (per manufacturer ' s instructions). In comparison, PCR/ESI-MS has been found to have sensitivity in the range of 0.5 -5 pg/sample ( ∼ 30 -300 fg per reaction, unpublished data). The software for both methods is user-friendly, with data analysis requiring only a short time for completion.
Rep-PCR has most widely been used for strain-typing of bacterial isolates, but a few studies have demonstrated its value for similar discrimination among clinical fungal isolates, including those of Aspergillus , Fusarium and thermally dimorphic fungi among others [9,10,22 -24] . One group has also shown the potential value of this method in species identifi cation of a narrow spectrum of Candida isolates [25] . However, the latter study included only the more commonly seen species.
PCR/ESI-MS has previously been most widely employed for the detection and identifi cation of bacterial and viral pathogens. Indeed, this method has shown promise as a high-throughput, broad range, and highly sensitive technique for either direct detection or isolate-based identifi cation. Published studies have indicated its value for outbreak investigations, detection of known genospecies, and as a potential pathogen discovery tool [12 -14,18,26] . Prior to the present work, very limited data have been published demonstrating the use of PCR/ESI-MS for identifi cation of unknown fungal isolates, although some have shown that another method, matrix-assisted laser desorption ionization time-of-fl ight mass spectrometry (MALDI-TOF MS) holds promise for this application [27, 28] .
PCR/ESI-MS has strong potential to be applied directly to clinical samples. Although the methodology is currently undergoing development and has not been fully vetted nor validated for direct clinical use, a number of direct authentic clinical blood specimens have been tested at Ibis Biosciences (data not shown) and Candida species have been correctly identifi ed through direct analysis (and confi rmed by culture). In addition, sensitivity of detection and correct identifi cation of Candida spp. DNA has been independently measured through DNA dilution to extinction experiments and been observed to be as low as 10 fg per reaction (160 fg total for the plate layout described herein, or 80 fg total for a Candida spp.-specifi c panel of eight primer pairs) for C. albicans and C. glabrata DNA. Note that these were isolated, purifi ed and pristine DNA samples in the absence of background and quantifi ed post-purifi cation. These data are not addressed in this manuscript as they are outside the scope of this study.
While including a wide spectrum of Candida isolates, the present study may still be improved by broadening the number and variety of well-validated reference strains. Three isolates of P. caribbica were identifi ed by rep-PCR as C. guilliermondii and by PCR/ESI-MS as C. guilliermondii (two isolates) and C. famata (one isolate). Sequence analysis revealed less than 1% sequence difference between P. caribbica (100% homology), C. famata and C. guilliermondii . Three isolates of C. pararugosa were present based on sequence analysis. None of these provided an identifi cation by rep-PCR. PCR/ESI-MS identifi ed one of these as C. rugosa and one as C. glabrata . The third isolate produced no identifi cation by PCR/ESI-MS. While these six species are unusual, their original (biochemical) identifi cations in the clinical laboratory were C. rugosa (all three C. pararugosa isolates), C. guilliermondii (two P. caribbica isolates ), and C. dubliniensis (one Pichia caribbica isolate). It is therefore possible that sequence-based identifi cation would reveal such species to be more common than is presently recognized. The present study did not include further expansion of the databases to include these species.
There was a single isolate which was unambiguously identifi ed as C. glabrata by both rep-PCR and PCR/ESI-MS but had been identifi ed as C. albicans by ITS sequencing. It is noteworthy that the rep-PCR and PCR/ESI-MS methods interrogate completely independent genomic regions and both came to the same identifi cation of C. glabrata . Moreover, the signature produced with the ESI-MS primer pair 3875 (GSC1, Table 1) produces two products in C. glabrata and one in C. albicans with quite distinct base compositions (not shown). In addition, different primer pairs are required to amplify the mtDNA SSU rRNA gene from C. albicans and C. glabrata (primer pairs 3865 and 3867, respectively, from Table 1 ). PCR/ESI-MS base composition signatures produced for C. albicans and C. glabrata are quite distinct and unmistakable for each of the two species. For these reasons, we feel it is most likely that an error occurred in the handling of one isolate during the sequencing preparation.
Many more clinical isolates will need to be tested to demonstrate the robustness of these methods. Furthermore, their prospective integration into clinical diagnostics will be needed to assess impact on clinical decision making, cost of care, and patient outcome. Nonetheless, these methods are user-friendly, objective, reproducible and require little prior expertise in molecular diagnostics. With accuracy equal to that of direct sequencing, they bring discriminative ability of a reference standard in a format that should be easy to integrate in labs previously unaccustomed to the high-complexity molecular methods. Innovations such as these should allow further dissemination of molecular diagnostic methods and their potentially significant clinical benefi ts.
